info@levinformulations.com
Toggle navigation
Home
About Us
Services
products
LEVITOR-10/20/40/80
LEVITOR-F
LEVITOR-CV10/CV20
LEVISAR-20/40
LEVISAR-H20/H40
Betamerit-XL 25/50
TELHART-20/40/80
TELHART-H40/H80
TELHART-M25/M50
ROZUHART-5/10/20
ROZUHART-CV 10
GILFORMIN-M1/M2/M3/M4
GILFORMIN-M1 Forte/M2 Forte/M3 Forte/M4 Forte
GILFORMIN-MV1/MV2
GILFORMIN-MP1/MP2
COBALFIT
COBALFIT-PLUS
COBALFIT-P
Gabafast-NT/NT100
LEVIRAB-20
LEVIRAB-DSR
NTROCAM 2.6
C3 FIT
C3 FIT-60K
VERTILIFE - 8/16/24
DAPAGARD-10
DAPAGARD-M10
LEVITOR-GOLD- 10/20
LINAPURE-2.5/5
ROZUHART-F10
VOGPURE M 0.2
LCFIT-M
AM3
PANKIN-40/DRS
TENAFIT-20/M
TELHART-3D
FERIFINE-XT
LETAGOLD-2.5
ZILFENAC-P
LEVIGRATE-OVA
LEVIGRATE-Q10
LEVIGRATE-Q10
LINAPURE-M 2.5/5
Contact Us
Products
GILFORMIN-MP1/MP2
GILFORMIN-MP1/MP2
Glimepiride 1mg/2mg + Pioglitazone 15mg + Metformin 500mg S.R.
Significant reduction in plasma lipids
In uncontrolled T 2 DM
First line therapy for glycemic control
For newly diagnosed Type 2 diabetic patients